Las Vegas, NV -- (SBWIRE) -- 12/31/2013 -- PennyStockEarnings team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks. Our Today’s Focus is on: Citigroup Inc (NYSE:C), DryShips Inc. (NASDAQ:DRYS), CytRx Corporation (NASDAQ:CYTR), Ariad Pharmaceuticals, Inc .(NASDAQ:ARIA)
Citigroup Inc (NYSE:C) managed to keep its fall at -0.65% on below -normal volume of 11.15M shares. The stock settled at $51.92 after floating in a range of $51.83 to $62.44. Its latest price has reached market capitalization of $157.47 billion. Its 52-week range has been $38.65 to $53.68. Citigroup Inc. (Citigroup) is a global diversified financial services holding company whose businesses provide consumers, corporations, governments and institutions with a broad range of financial products and services, including consumer banking and credit, corporate and investment banking, securities brokerage, transaction services and wealth management.
Has C Found The Bottom and Ready To Move Up? Find Out Here
DryShips Inc. (NASDAQ:DRYS) traded down on a volume of 27.56 million, higher than its standard daily volume. Shares have dropped-6.41% to $4.38. Over the last twelve months, the stock has gained 5.04% and faced a worst price of $1.53. DryShips Inc. (DryShips) is a holding company engaged in the ocean transportation services of drybulk cargoes and crude oil worldwide through the ownership and operation of drybulk carrier vessels and oil tankers and offshore drilling services through the ownership and operation of ultra-deepwater drilling units.
Has DRYS Found The Bottom And Ready To Gain Momentum? Find Out Here
CytRx Corporation (NASDAQ:CYTR) settled 10.08% higher at $5.79 on above-normal volume of 8.77M shares during the last trading day. The stock has its 12-month high at $6.79 and 52-week low price was $1.80. It traded in a range of $5.45 to $6.30 during the last trading day. CytRx Corporation (CytRx) is a biopharmaceutical research and development company specializing in oncology.
Why Should Investors Buy CYTR After the Recent Fall? Just Go Here and Find Out
In the last trading session, Ariad Pharmaceuticals, Inc .(NASDAQ:ARIA) was down on low volume, trading at a volume of 21.62M shares versus its average daily volume of 33.25 million shares. At $6.55, the stock has attained market capitalization of $1.22 billion. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic.
Why Should Investors Buy ARIA After the Recent Fall? Just Go Here and Find Out
PennyStockEarnings.com is keen to discover penny stocks with the potential to make short and long-term gains.
PSE Team record for picking gainers is one of the best in the business, and our followers continue to make substantial profits – even in bear markets. Our Team includes top analysts and use level II screeners to get you the information you need to make intelligent decisions for trading penny stocks.
PLEASE NOTE WELL: The employees of PennyStockEarnings.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockEarnings.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockEarnings.com is not offering securities for sale. Neither PennyStockEarnings.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockEarnings.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockEarnings.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer Here: http://www.pennystockearnings.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)